Central regions | Technology & innovation

Nanoparticles and protein can challenge cancer

2 Dec '22
Russian scientists have developed new polymer-based nanoparticles for targeted delivery of anti-tumor drugs.

A collaborative team from Mendeleev University and two more Moscow-based research hubs has come up with nanoparticles that, when bonded to a specific protein called cytokine (designated TRAIL DR5), become capable of causing death of cancer cells. In the experiments, the cytokine closely interacted with the so-called death receptors on the surface of tumorous cells, thus triggering their self-destruction.

The human body is a self-regulating system that always keeps cells growth and development under control. The system marks the cells in which pathological change has been spotted, and then kick-starts the process of their self-annihilation. The cytokine proteins play a crucial role in this and have long been looked into as possible vehicles for cancer therapy.

Many attempts have been made across the world to harness the counter-tumor properties of the cytokine since the TRAIL was first discovered 25 or so years ago. Serious problems have been faced in the process, though. The TRAIL works with some cancer types and fails with others; why some tumorous cells can resist the protein and others cant has yet to be fully understood. In addition, the human body may or may not generate enough cytokines to inhibit a tumor as it starts growing. The free (unbonded) TRAIL could be administered artificially, but the kidneys discharge it too fast for the protein to be able to do its expected job.

According to Dr. Andrei Kuskov of Mendeleev University, one of the co-experimenters, his team secured the molecules of the DR5-specific cytokine on the surface of polymer-based nanoparticles. The researchers found that the protein-nanoparticles conjugation stepped up the cytokines ability to kill cancer cells. Whats more, it took much fewer cytokines in their bonded form to achieve good enough therapeutic effect - just one-tenth of what would have been needed if the free protein had been used.

It is critical to note that healthy human cells that surrounded the cancer ones were left unscathed in the experiment. Research with breast adenocarcinoma cells has led the team to believe that the DR5-specific cytokine concentrates on its target and sends afflicted cells a very powerful signal that triggers their self-destruction.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
Find Related Content

Locations: Moscow

Tags: self destruction (0) / polymer based nanoparticles (0) / cytokine (0) / cancer cells (0) / TRAIL DR5 (0) / Mendeleev University (0) / Andrei Kuskov (0) /

Latest News: Central regions
19 Jan '23 | Technology & innovation
27 Dec '22 | Technology & innovation
22 Dec '22 | Energy, utilities | Technology & innovation
15 Dec '22 | Technology & innovation

Feature stories

23 Dec '22
Chemists at the Tomsk State University (TSU) in...
8 Nov '22
Cerebral vascular disorders are responsible for a...
5 Sep '22
Scientists at the Moscow Lomonosov State University...
Search (News archive - 22997)
Technology Scouting Solutions For Industry
Marchmont News

Latest News

26 Jan '23
Scientists in the Urals region experimented with...
25 Jan '23
Scientists in St. Petersburg applied a new version of...
23 Jan '23
A new method of conducting radiotherapy without...

Most read stories from last week